Novel epigenetic based differentiation therapy for Acute Myeloid Leukemia
Edurne San José‐Eneriz(Universidad de Navarra), Felipe Prósper(Clinica Universidad de Navarra)
Cited by 0
Related Papers
Deregulation of <i>FGFR1</i> and <i>CDK6</i> oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the <i>MIR9</i> family
|British Journal of Haematology|2011|60
Frequent and Simultaneous Epigenetic Inactivation of TP53 Pathway Genes in Acute Lymphoblastic Leukemia
|PLoS ONE|2011|57
The transcription factor DDIT3 is a potential driver of dyserythropoiesis in myelodysplastic syndromes
|Nature Communications|2022|26
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
|Nature Communications|2024|9